Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BAJAJHCARE | NSE
-1.05
-0.36%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/06/2026
293.50
296.10
298.40
292.00
Bajaj HealthCare Limited a pharmaceutical company develops manufactures and supplies amino acids nutritional supplements and active pharmaceutical ingredients (APIs) for pharmaceutical nutraceuticals and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic antibiotic antiviral antiplatelet antifungal antihelmintic iron-chelating agent anticonvulsant growth stimulant non-steroidal anti-inflammatory drugs antihypertensive anthelmintics anti-asthmatic antioxidant urinary tract infection anti-histamine weight reducing venous disease antimalarial vitamin c disinfectant/ antiseptic stimulant anticonvulsant lipotropic agents nootropic vasoprotective/ antihemorrhagic cardiovascular agents food supplements anti-anemic amino acids antiasthmatic / bronchodilator nutritional supplement and minerals. It also provides formulations in the form of tablets capsules and oral powder as well as intermediates and impurities. In addition the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane India.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
21.8%1 month
48.4%3 months
51.1%6 months
43.4%-
-
4.33
1.20
0.43
35.04
3.24
-
834.83M
9.22B
97.08M
0.26
13.44
-79.50
1.90
-4.44
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
24.50
Range1M
75.65
Range3M
89.55
Rel. volume
0.31
Price X volume
19.30M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 104.34 | 9.68B | -2.14% | 49.05 | 25.36% |
| Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 158 | 9.34B | 0.84% | 1.92 | 1.78% |
| Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 262.3 | 8.59B | 1.61% | 15.72 | 416.89% |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 131.68 | 7.80B | -3.29% | 20.75 | 2.03% |
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 203.04 | 5.39B | -0.20% | 61.65 | 4.77% |
| Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 105.12 | 5.13B | -2.31% | 29.93 | 45.58% |
| TAKE Solutions Limited | TAKE | Biotechnology | 29.57 | 4.37B | -0.34% | n/a | -417.95% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 176.34 | 4.19B | 10.00% | 674.92 | 30.17% |
| Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 710.75 | 4.07B | -1.21% | 9.51 | 0.87% |
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 45.52 | 3.62B | -0.85% | 45.53 | 15.37% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 306.65 | 9.91B | -4.99% | 36.36 | 52.08% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 247.99 | 8.85B | -3.28% | 120.49 | 191.28% |
| Madhav Copper Limited | MCL | Copper | 59.6 | 1.64B | -0.28% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.92 | 1.26B | -0.36% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 70.46 | 785.54M | -2.29% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24.6 | 427.05M | -3.42% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.24 | 158.63M | 3.43% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 35.04 | 24.85 | Expensive |
| Ent. to Revenue | 3.24 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 4.33 | 6.83 | Cheaper |
| Dividend Yield | 0.26 | 0.52 | Poor |
| Std. Deviation (3M) | 51.08 | 42.17 | Riskier |
| Debt to Equity | 1.20 | 0.35 | Expensive |
| Debt to Assets | 0.43 | 0.17 | Expensive |
| Market Cap | 9.22B | 290.82B | Emerging |